Option Care Health, Inc. (OPCH)
USD 22.78
(-2.73%)
USD 22.78
(-2.73%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 314.59 Million USD | 30.96% |
| 2022 | 240.23 Million USD | 25.88% |
| 2021 | 190.84 Million USD | 72.31% |
| 2020 | 110.75 Million USD | 2577.74% |
| 2019 | -4.47 Million USD | 91.34% |
| 2018 | -51.59 Million USD | -445.74% |
| 2017 | 14.92 Million USD | 103.35% |
| 2016 | 7.33 Million USD | 102.55% |
| 2015 | -287.64 Million USD | -215.82% |
| 2014 | -91.07 Million USD | -1206.17% |
| 2013 | -6.97 Million USD | -152.48% |
| 2012 | 13.28 Million USD | -71.35% |
| 2011 | 46.38 Million USD | 193.69% |
| 2010 | 15.79 Million USD | 2.12% |
| 2009 | 15.46 Million USD | -81.48% |
| 2008 | 83.51 Million USD | 843.59% |
| 2007 | 8.85 Million USD | -45.5% |
| 2006 | 16.24 Million USD | -44.39% |
| 2005 | 29.2 Million USD | 137.54% |
| 2004 | 12.29 Million USD | -23.28% |
| 2003 | 16.02 Million USD | -33.64% |
| 2002 | 24.14 Million USD | 58.97% |
| 2001 | 15.19 Million USD | 8386.03% |
| 2000 | 179 Thousand USD | -85.47% |
| 1999 | 1.23 Million USD | -80.44% |
| 1998 | 6.3 Million USD | 139.87% |
| 1997 | -15.8 Million USD | -147.73% |
| 1996 | 33.1 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 80.67 Million USD | 16.87% |
| 2024 Q1 | 69.03 Million USD | -18.36% |
| 2024 Q3 | 85.09 Million USD | 5.47% |
| 2023 FY | 314.59 Million USD | 30.96% |
| 2023 Q1 | 66.62 Million USD | -2.3% |
| 2023 Q2 | 82.36 Million USD | 23.63% |
| 2023 Q3 | 81.04 Million USD | -1.6% |
| 2023 Q4 | 84.55 Million USD | 4.33% |
| 2022 Q3 | 60.71 Million USD | 2.78% |
| 2022 Q4 | 68.19 Million USD | 12.31% |
| 2022 Q1 | 52.24 Million USD | -14.03% |
| 2022 Q2 | 59.07 Million USD | 13.07% |
| 2022 FY | 240.23 Million USD | 25.88% |
| 2021 Q3 | 52.88 Million USD | 9.96% |
| 2021 Q4 | 60.77 Million USD | 14.92% |
| 2021 Q1 | 29.09 Million USD | -34.39% |
| 2021 FY | 190.84 Million USD | 72.31% |
| 2021 Q2 | 48.09 Million USD | 65.3% |
| 2020 Q3 | 34.55 Million USD | 48.9% |
| 2020 Q1 | 8.64 Million USD | -38.11% |
| 2020 Q2 | 23.2 Million USD | 168.36% |
| 2020 Q4 | 44.34 Million USD | 28.32% |
| 2020 FY | 110.75 Million USD | 2577.74% |
| 2019 Q1 | -5.11 Million USD | -192.52% |
| 2019 Q4 | 13.97 Million USD | 219.17% |
| 2019 Q3 | -11.72 Million USD | -220.08% |
| 2019 Q2 | 9.76 Million USD | 291.08% |
| 2019 FY | -4.47 Million USD | 91.34% |
| 2018 Q4 | 5.52 Million USD | -41.56% |
| 2018 Q2 | 3.79 Million USD | 370.2% |
| 2018 Q1 | -1.4 Million USD | -116.3% |
| 2018 FY | -51.59 Million USD | -445.74% |
| 2018 Q3 | 9.45 Million USD | 148.75% |
| 2017 FY | 14.92 Million USD | 103.35% |
| 2017 Q2 | 2.78 Million USD | 15.88% |
| 2017 Q3 | 5.91 Million USD | 112.24% |
| 2017 Q4 | 8.62 Million USD | 45.8% |
| 2017 Q1 | 2.4 Million USD | 3.22% |
| 2016 FY | 7.33 Million USD | 102.55% |
| 2016 Q3 | 4.35 Million USD | 232.54% |
| 2016 Q2 | 1.3 Million USD | 202.83% |
| 2016 Q1 | -1.27 Million USD | 80.16% |
| 2016 Q4 | 2.33 Million USD | -46.47% |
| 2015 Q2 | -254 Million USD | -5176.38% |
| 2015 Q3 | -19.28 Million USD | 92.41% |
| 2015 Q4 | -6.41 Million USD | 66.72% |
| 2015 FY | -287.64 Million USD | -215.82% |
| 2015 Q1 | -4.81 Million USD | 89.83% |
| 2014 Q4 | -47.31 Million USD | -81.42% |
| 2014 Q2 | -6.41 Million USD | 43.9% |
| 2014 FY | -91.07 Million USD | -1206.17% |
| 2014 Q1 | -11.43 Million USD | -139.21% |
| 2014 Q3 | -26.08 Million USD | -306.71% |
| 2013 Q3 | 51 Thousand USD | 103.89% |
| 2013 Q4 | -4.77 Million USD | -9470.59% |
| 2013 FY | -6.97 Million USD | -152.48% |
| 2013 Q1 | -934 Thousand USD | -129.67% |
| 2013 Q2 | -1.31 Million USD | -40.36% |
| 2012 Q2 | 2.86 Million USD | -29.25% |
| 2012 Q4 | 3.14 Million USD | -7.03% |
| 2012 Q1 | 4.04 Million USD | -72.8% |
| 2012 FY | 13.28 Million USD | -71.35% |
| 2012 Q3 | 3.38 Million USD | 18.35% |
| 2011 Q2 | 4.52 Million USD | -56.65% |
| 2011 Q3 | 7.92 Million USD | 75.34% |
| 2011 Q1 | 10.42 Million USD | 387.54% |
| 2011 Q4 | 14.86 Million USD | 87.52% |
| 2011 FY | 46.38 Million USD | 193.69% |
| 2010 Q2 | 13.51 Million USD | 114.5% |
| 2010 FY | 15.79 Million USD | 2.12% |
| 2010 Q4 | -3.62 Million USD | -129.72% |
| 2010 Q1 | 6.3 Million USD | 1050.53% |
| 2010 Q3 | 12.2 Million USD | -9.72% |
| 2009 Q3 | 6.66 Million USD | 28.49% |
| 2009 FY | 15.46 Million USD | -81.48% |
| 2009 Q4 | -663 Thousand USD | -109.95% |
| 2009 Q2 | 5.18 Million USD | 21.04% |
| 2009 Q1 | 4.28 Million USD | -94.45% |
| 2008 FY | 83.51 Million USD | 843.59% |
| 2008 Q4 | 77.15 Million USD | 2646.71% |
| 2008 Q1 | 185 Thousand USD | -93.95% |
| 2008 Q2 | 3.36 Million USD | 1720.54% |
| 2008 Q3 | 2.8 Million USD | -16.6% |
| 2007 Q1 | 136 Thousand USD | -94.24% |
| 2007 FY | 8.85 Million USD | -45.5% |
| 2007 Q4 | 3.05 Million USD | -3.01% |
| 2007 Q3 | 3.15 Million USD | 26.01% |
| 2007 Q2 | 2.5 Million USD | 1740.44% |
| 2006 Q1 | 1.6 Million USD | -94.15% |
| 2006 Q2 | 8.3 Million USD | 416.17% |
| 2006 Q3 | 3.97 Million USD | -52.14% |
| 2006 Q4 | 2.36 Million USD | -40.53% |
| 2006 FY | 16.24 Million USD | -44.39% |
| 2005 FY | 29.2 Million USD | 137.54% |
| 2005 Q1 | 2.88 Million USD | 50.65% |
| 2005 Q2 | 5.66 Million USD | 96.29% |
| 2005 Q3 | 1.59 Million USD | -71.91% |
| 2005 Q4 | 27.47 Million USD | 1626.96% |
| 2004 Q2 | 3.47 Million USD | -9.25% |
| 2004 Q3 | 3.07 Million USD | -11.54% |
| 2004 Q4 | 1.91 Million USD | -37.7% |
| 2004 Q1 | 3.82 Million USD | 122.1% |
| 2004 FY | 12.29 Million USD | -23.28% |
| 2003 Q1 | 5.92 Million USD | 5.56% |
| 2003 Q4 | 1.72 Million USD | -25.01% |
| 2003 Q3 | 2.29 Million USD | -62.16% |
| 2003 Q2 | 6.07 Million USD | 2.5% |
| 2003 FY | 16.02 Million USD | -33.64% |
| 2002 Q3 | 5.83 Million USD | -2.81% |
| 2002 Q4 | 5.61 Million USD | -3.77% |
| 2002 Q2 | 6 Million USD | -10.31% |
| 2002 Q1 | 6.69 Million USD | 108.02% |
| 2002 FY | 24.14 Million USD | 58.97% |
| 2001 Q3 | 4.77 Million USD | 36.21% |
| 2001 Q4 | 3.21 Million USD | -32.59% |
| 2001 Q1 | 3.69 Million USD | 441.4% |
| 2001 Q2 | 3.5 Million USD | -5.12% |
| 2001 FY | 15.19 Million USD | 8386.03% |
| 2000 Q2 | 759 Thousand USD | 127.25% |
| 2000 Q4 | -1.08 Million USD | -744.05% |
| 2000 Q3 | 168 Thousand USD | -77.87% |
| 2000 FY | 179 Thousand USD | -85.47% |
| 2000 Q1 | 334 Thousand USD | 591.18% |
| 1999 Q2 | 500 Thousand USD | 25.0% |
| 1999 Q4 | -68 Thousand USD | -122.67% |
| 1999 Q3 | 300 Thousand USD | -40.0% |
| 1999 Q1 | 400 Thousand USD | -78.95% |
| 1999 FY | 1.23 Million USD | -80.44% |
| 1998 Q4 | 1.9 Million USD | 5.56% |
| 1998 FY | 6.3 Million USD | 139.87% |
| 1998 Q1 | 1.1 Million USD | 108.94% |
| 1998 Q2 | 1.4 Million USD | 27.27% |
| 1998 Q3 | 1.8 Million USD | 28.57% |
| 1997 Q4 | -12.3 Million USD | -251.43% |
| 1997 Q3 | -3.5 Million USD | -1850.0% |
| 1997 Q2 | 200 Thousand USD | 100.0% |
| 1997 Q1 | 100 Thousand USD | -98.7% |
| 1997 FY | -15.8 Million USD | -147.73% |
| 1996 FY | 33.1 Million USD | 0.0% |
| 1996 Q1 | 67.7 Million USD | 0.0% |
| 1996 Q4 | 7.7 Million USD | 755.56% |
| 1996 Q3 | 900 Thousand USD | -98.67% |
| 1996 Q2 | 67.7 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 37.9% |
| Addus HomeCare Corporation | 90.95 Million USD | -245.876% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -3217.463% |
| Amedisys, Inc. | 156.39 Million USD | -101.155% |
| American Oncology Network, Inc. | -49.15 Million USD | 740.019% |
| Astrana Health, Inc. | 84.61 Million USD | -271.805% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -3797.361% |
| IMAC Holdings, Inc. | -6.37 Million USD | 5034.43% |
| biote Corp. | 28.65 Million USD | -997.795% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 2656.845% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | -179.112% |
| COMPASS Pathways plc | -136.91 Million USD | 329.767% |
| DocGo Inc. | 15.05 Million USD | -1989.641% |
| The Ensign Group, Inc. | 255.36 Million USD | -23.193% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -404.498% |
| InnovAge Holding Corp. | -23.18 Million USD | 1457.183% |
| Assure Holdings Corp. | -20.08 Million USD | 1666.552% |
| The Joint Corp. | -2.07 Million USD | 15275.195% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 266.334% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 2103.312% |
| ModivCare Inc. | -139.94 Million USD | 324.797% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -744644.567% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 3778.113% |
| P3 Health Partners Inc. | -167.86 Million USD | 287.415% |
| P3 Health Partners Inc. | -167.86 Million USD | 287.415% |
| The Pennant Group, Inc. | 25.16 Million USD | -1149.93% |
| Surgery Partners, Inc. | 328 Million USD | 4.087% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 10994.691% |
| Talkspace, Inc. | -23.2 Million USD | 1455.487% |
| Talkspace, Inc. | -23.2 Million USD | 1455.487% |
| The Oncology Institute, Inc. | -77.01 Million USD | 508.469% |
| The Oncology Institute, Inc. | -77.01 Million USD | 508.469% |